177 related articles for article (PubMed ID: 2295451)
1. Survival of patients with ovarian epithelial carcinomas after second-look laparotomy.
Podczaski E; Manetta A; Kaminski P; Ricelli A; Larson J; DeGeest K; Mortel R
Gynecol Oncol; 1990 Jan; 36(1):43-7. PubMed ID: 2295451
[TBL] [Abstract][Full Text] [Related]
2. Use of second-look laparotomy in the management of patients with ovarian epithelial malignancies.
Podczaski ES; Stevens CW; Manetta A; Whitney CW; Larson JE; Mortel R
Gynecol Oncol; 1987 Oct; 28(2):205-14. PubMed ID: 3666578
[TBL] [Abstract][Full Text] [Related]
3. Use of CA 125 to monitor patients with ovarian epithelial carcinomas.
Podczaski E; Whitney C; Manetta A; Larson JE; Kirk J; Stevens CW; Lyter J; Mortel R
Gynecol Oncol; 1989 May; 33(2):193-7. PubMed ID: 2703180
[TBL] [Abstract][Full Text] [Related]
4. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration.
Lippman SM; Alberts DS; Slymen DJ; Weiner S; Aristizabal SA; Luditch A; Davis JR; Surwit EA
Cancer; 1988 Jun; 61(12):2571-7. PubMed ID: 3365677
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer.
Jacob JH; Gershenson DM; Morris M; Copeland LJ; Burke TW; Wharton JT
Gynecol Oncol; 1991 Aug; 42(2):146-50. PubMed ID: 1894174
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-containing versus cisplatin-free adjuvant chemotherapy in ovarian carcinoma. Results after second-look laparotomy.
Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
Oncology; 1990; 47(2):109-11. PubMed ID: 2314822
[TBL] [Abstract][Full Text] [Related]
7. Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patients.
de Gramont A; Drolet Y; Varette C; Louvet C; Gonzalez-Canall G; Krulik M; Cady J; Pigne A; Marpeau L; Barrat J
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):451-7. PubMed ID: 2702999
[TBL] [Abstract][Full Text] [Related]
8. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
9. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT
Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
[TBL] [Abstract][Full Text] [Related]
10. Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.
Hoskins WJ; Rubin SC; Dulaney E; Chapman D; Almadrones L; Saigo P; Markman M; Hakes T; Reichman B; Jones WB
Gynecol Oncol; 1989 Sep; 34(3):365-71. PubMed ID: 2548935
[TBL] [Abstract][Full Text] [Related]
11. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.
Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F
Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918
[TBL] [Abstract][Full Text] [Related]
12. A second thought on second look laparotomy.
Bar-Am A; Kovner F; Lessing JB; Inbar M; Chaitchik S; Azem F; Brenner SH; Peyser MR
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):386-90. PubMed ID: 8392272
[TBL] [Abstract][Full Text] [Related]
13. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
14. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
15. Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients.
Bozkurt N; Yuce K; Basaran M; Gariboglu S; Kose F; Ayhan A
Int J Gynecol Cancer; 2006; 16(1):83-6. PubMed ID: 16445615
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study.
Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543
[TBL] [Abstract][Full Text] [Related]
17. Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study).
Creasman WT; Gall S; Bundy BN; Beecham J; Mortel R; Homesley HD
Gynecol Oncol; 1989 Dec; 35(3):378-82. PubMed ID: 2599475
[TBL] [Abstract][Full Text] [Related]
18. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.
Rubin SC; Randall TC; Armstrong KA; Chi DS; Hoskins WJ
Obstet Gynecol; 1999 Jan; 93(1):21-4. PubMed ID: 9916949
[TBL] [Abstract][Full Text] [Related]
19. The value of second-look operation in patients with advanced epithelial ovarian carcinoma.
Sevelda P; Dittrich C; Salzer H
Arch Gynecol Obstet; 1989; 244(2):79-86. PubMed ID: 2712601
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
